At Biologics by McKesson, proactive pharmacy care and personalized support help patients stay on therapies, reduce costs and improve outcomes.
Making a Real Difference for Patients Living with Cancer
McKesson is uniquely positioned to advance cancer care.
Treating cancer is becoming increasingly complex. More than ever, oncologists need the right solutions and technologies to provide the best possible care to their patients.
At McKesson, our legacy of oncology innovation runs deep. We support an unparalleled network of oncology providers to give patients access to life-changing therapies. See how our patient-first approach and unparalleled suite of cancer offerings help enhance patients’ lives.
To learn more, visit: McKesson Oncology Solutions.
Related Stories
Sarah Cannon Research Institute (SCRI) offers clinical trials in communities close to home, where 85% of patients seek care.
How Shenandoah Oncology became a blueprint for compassion and turned patient feedback into a lifeline.
How community oncology clinics are helping break down barriers to care.
How Biopharma and community oncology are working together to solve healthcare’s toughest challenges and build a more resilient future for cancer care.
Meeting the demands of ultra-sensitive treatments with purpose-built storage, automation and pharmacy integration
In the third episode of our Always Advancing video series, learn how precision and personalized medicine are transforming cancer care – expanding access to clinical trials and novel treatments in communities.
Using McKesson Compile’s analytics to transform how patients with rare blood disorders access specialized care across Indiana.
InspiroGene by McKesson helps patients with rare and severe diseases access innovative cell and gene therapies through personalized support at every step of their journey.
How McKesson’s Precision Care Companion is advancing genomic testing, therapy selection and collaboration in community oncology. How McKesson’s Precision Care Companion is advancing genomic testing, therapy selection and collaboration in community oncology.